A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis

Clinical and Experimental Allergy

Volumn 34, Issue 4, 2004, Pages 646-649

  Lee, D K C ^a   Gray, R D ^a   Robb, F M ^a   Fujihara, S ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenosine monophosphate; Butterbur; Fexofenadine; H1 antihistamine; Nasal challenge; Peak nasal inspiratory flow; Perennial allergic rhinitis; Petasin; petasites hybridus

Indexed keywords

ADENOSINE PHOSPHATE; FEXOFENADINE; HERBACEOUS AGENT; PETAFORCE; PETASITES HYBRIDUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; INSPIRATORY CAPACITY; MALE; PERENNIAL RHINITIS; PETASITES; PETASITES HYBRIDUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTI-ALLERGIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; PETASITES; PHYTOTHERAPY; PLANT EXTRACTS; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; TERFENADINE; TREATMENT OUTCOME;

EID: 2042544769     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.1903.x     Document Type: Article

References (18)

1. Thomet OA, Wiesmann UN, Blaser K, Simon HU. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. Clin Exp Allergy 2001; 31:1310-20.
2. Brune K, Bickel D, Peskar BA. Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptidoleukotriene synthesis. Planta Med 1993; 59:494-6.
3. Bickel D, Roder T, Bestmann HJ, Brune K. Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus. Planta Med 1994; 60:318-22.
4. Thomet OA, Wiesmann UN, Schapowal A, Bizer C, Simon H. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem Pharmacol 2001; 61:1041-7.
5. Thomet OA, Schapowal A, Heinisch IV, Wiesmann UN, Simon HU. Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. J Immunopharmacol 2002; 2:997-1006.
6. Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ 2002; 324:144.
7. Lee DK, Gray RD, Lipworth BJ. Adenosine monophosphate bronchial provocation and the actions of asthma therapy. Clin Exp Allergy 2003; 33:287-94.
8. Lee DK, Bates CE, Currie GP, Lipworth BJ. Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. J Allergy Clin Immunol 2003; 111:337-41.
9. Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003; 167:1232-8.
10. Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, Lipworth BJ. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 2003; 33:882-6.
11. Wilson AM, Sims EJ, Robb F, Cockburn W, Lipworth BJ. Peak inspiratory flow rate is more sensitive than acoustic rhinometry or rhinomanometry in detecting corticosteroid response with nasal histamine challenge. Rhinology 2003; 41:16-20.
12. Holgate ST. Adenosine provocation: a new test for allergic type airway inflammation. Am J Respir Crit Care Med 2002; 165:317-8.
13. Wilson AM, Sims EJ, Orr LC, Robb F, Lipworth BJ. An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge. Br J Clin Pharmacol 2003; 55:354-9.
14. Paolieri F, Battifora M, Riccio AM et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998; 81:601-7.
15. Abdelaziz MM, Devalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998; 101:410-20.
16. Marone G, Gentile M, Petraroli A, De Rosa N, Triggiani M. Histamine-induced activation of human lung macrophages. Int Arch Allergy Immunol 2001; 124:249-52.
17. Triggiani M, Gentile M, Secondo A et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001; 166:4083-91.
18. Hoda U, Lau LCK, Leir SH, Howarth PH. Influence of fexofenadine on tumour necrosis factor alpha stimulated H292 epithelial cell activation in vitro. Allergy 2002; 57 (Suppl. 73):146.